Observational studyPharmacogenomics2020

Projected impact of pharmacogenomic testing on medications beyond antiplatelet therapy in percutaneous coronary intervention patients.

Rachel M Black et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.